Clinical Trials Browser

Phase 1/2 × Leukemia, Myeloid, Acute × Sunitinib × Clear all

NCT00783653 2020-02-25

Clinical Study of SU 11248 (Sutent) Combined With Standard Chemotherapy in Patients With FLT3 Mutated AML Over 60 Years

Phase 1/2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute